中国现代医药杂志
中國現代醫藥雜誌
중국현대의약잡지
Modern Medicine Journal of China
2015年
9期
26-28
,共3页
张翠红%于志红%张岿%杨国辉
張翠紅%于誌紅%張巋%楊國輝
장취홍%우지홍%장규%양국휘
重复经颅磁刺激%精神分裂症%阴性症状
重複經顱磁刺激%精神分裂癥%陰性癥狀
중복경로자자격%정신분렬증%음성증상
Repetitive transcranial magnetic stimulation%Schizophrenia%Negative symptom
目的:探讨重复经颅磁刺激(rTMS)联合齐拉西酮在精神分裂症阴性症状中的临床治疗效果。方法将70例住院慢性精神分裂症患者随机分为实验组和对照组各35例,两组均采用以齐拉西酮为主的药物治疗,实验组给予经左侧前额叶背外侧皮质高频rTMS刺激,对照组给予伪刺激。于治疗前及治疗4周末应用阳性与阴性症状量表(PANSS)评定疗效。结果治疗4周后,两组PANSS总分及各因子评分较治疗前明显降低(P<0.01)。两组间比较,治疗后两组PANSS评分P分(阳性症状)和G分(一般精神病理症状)无明显变化(P>0.05),而N分(阴性症状)和总分有明显差异(P<0.01),实验组分值下降更明显。结论 rTMS合并齐拉西酮能有效改善慢性精神分裂症的阴性症状。
目的:探討重複經顱磁刺激(rTMS)聯閤齊拉西酮在精神分裂癥陰性癥狀中的臨床治療效果。方法將70例住院慢性精神分裂癥患者隨機分為實驗組和對照組各35例,兩組均採用以齊拉西酮為主的藥物治療,實驗組給予經左側前額葉揹外側皮質高頻rTMS刺激,對照組給予偽刺激。于治療前及治療4週末應用暘性與陰性癥狀量錶(PANSS)評定療效。結果治療4週後,兩組PANSS總分及各因子評分較治療前明顯降低(P<0.01)。兩組間比較,治療後兩組PANSS評分P分(暘性癥狀)和G分(一般精神病理癥狀)無明顯變化(P>0.05),而N分(陰性癥狀)和總分有明顯差異(P<0.01),實驗組分值下降更明顯。結論 rTMS閤併齊拉西酮能有效改善慢性精神分裂癥的陰性癥狀。
목적:탐토중복경로자자격(rTMS)연합제랍서동재정신분렬증음성증상중적림상치료효과。방법장70례주원만성정신분렬증환자수궤분위실험조화대조조각35례,량조균채용이제랍서동위주적약물치료,실험조급여경좌측전액협배외측피질고빈rTMS자격,대조조급여위자격。우치료전급치료4주말응용양성여음성증상량표(PANSS)평정료효。결과치료4주후,량조PANSS총분급각인자평분교치료전명현강저(P<0.01)。량조간비교,치료후량조PANSS평분P분(양성증상)화G분(일반정신병리증상)무명현변화(P>0.05),이N분(음성증상)화총분유명현차이(P<0.01),실험조분치하강경명현。결론 rTMS합병제랍서동능유효개선만성정신분렬증적음성증상。
Objective To evaluate the effect of repetitive transcranial magnetic stimulation (rTMS) combined with ziprasidone clinical outcomes in the negative symptoms of schizophrenia. Methods 70 patients with schizophrenia were ran-domly assigned into experimental group(n=35) and control group(n=35). Two groups used ziprasidone based on drug treatment, the experimental group received the left dorsolateral prefrontal cortex in hight-frequency rTMS stimulation ,the control group was given pseudo stimulation. Positive and negative symptoms scale (PANSS) were assessed before and at 4 weeks of treatment. Results After 4 weeks of treatment, the total score of PANSS and the score of each factor were significantly decreased (P<0.01). The PANSS score of two groups after treatment P (postitive) and G (general mental pathological sympotoms) had no sig-nificant difference (P>0.05), but N (negative symptoms) and total score had significant difference (P<0.01). The score of the experimental group was more obvious. Conclusion rTMS combined with ziprasidone can reduce the severity of negative symptoms in schizophrenia.